Skip to main content
. 2019 Aug 26;21(8):e13408. doi: 10.2196/13408

Table 1.

Descriptive statistics of the study population.

Study sample, characteristic Study sample 1 (N=288) Study sample 2 (N=566) Study sample 3 (N=526)
Age, mean (SD) 58.12 (11.26) 64.18 (10.65) 59.00 (50-66)a
Gender, n (%)

Male 126 214 259

Female 177 351 267
Diagnosis, n (%)

Breast cancer 82 (26.9) 222 (39.2) b

Miscellaneous cancer 47 (15.4)

Prostate cancer 42 (13.8)

Lymphoma 20 (6.5) 68 (12.0)

Colon cancer 18 (5.9)

Skin cancer 18 (5.9)

Lung cancer 17 (5.5)

Bladder and kidney cancer 17 (5.5)

Rectal cancer 14 (4.6)

Head and neck cancer 12 (3.9) 108 (19.1)

Esophageal cancer 10 (3.2)

Leukemia 10 (3.2)

Other 33 (8.8)

Colorectal cancer 168 (29.7)

Total knee arthroplasty 164 (31.2)

Total hip arthroplasty 89 (16.9)

Anterior cruciate ligament reconstruction 56 (10.6)

Knee arthroscopy 47 (8.9)

Cuff repair 30 (5.7)

High tibial osteotomy 23 (4.4)

Lumbar discectomy 17 (3.2)

Acromionplasty 14 (2.7)

Remaining group 86 (16.3)

aMedian (interquartile range).

bNot assessed in this study.

cRemaining group: shoulder arthroplasty, femoral osteotomy, patella stabilization (medial patellofemeral ligament), mortons neurom, hallux valgus/rigidus, exostosis, and talocrual arthrodesis.